P
Description
Clinical-stage Israeli pharmaceutical company specializing in reformulation of established therapeutics. Lead product PRF-110: extended-release oil-based ropivacaine solution for opioid-free post-surgical pain relief. Phase 3 in bunionectomy. Listed on NASDAQ.